Household Malaysian Community
Our community narratives are driven by numbers and valuation.
Household Malaysian Investing Ideas
Sunzen Biotech Positive Performance
Sunzen Biotech Berhad: Q1 FY25 Financial Insights and Technical Outlook Financial Performance Overview Sunzen Biotech Berhad posted a stable financial performance for Q1 FY25, achieving a revenue of RM22.96 million, an 11.42% increase compared to the preceding quarter. Key contributors were: • Human Health Segment: RM17.65 million in revenue, driven by robust export sales of edible bird’s nests to China, constituting 79.32% of segment revenue.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
ON
RM 0.47
43.6% undervalued intrinsic discount
Ontological's Fair Value
Revenue
18% p.a.
Profit Margin
6.34%
Future PE
40.14x
Price in 2029
RM 0.74
